New Hepatitis-C drug raises hope at a hefty price
Clip: 04/23/2014 | 7m 36s
A new drug has a 90 to 100 percent chance of curing the Hepatitis C virus, but costs tens of thousands of dollars for a course of treatment. The announcement by the manufacturer that it earned more than $2 billion in the year’s first quarter raises the question, who should pay when drugs are highly effective, but extremely expensive? Hari Sreenivasan reports on the profits, coverage and costs.
The full episode is no longer available for online streaming. Why?
Please continue to enjoy extra(s) from this episode.